Achilles Therapeutics (ACHL) Earnings Date & Reports

A.I. Advisor

published Earnings

ACHL is expected to report earnings to fall 2.44% to -40 cents per share on November 05

Achilles Therapeutics ACHL Stock Earnings Reports

Q3'24

Est.

$-0.40

Q2'24

Est.

$-0.41

Q1'24

Beat

by $0.16

Q4'23

Missed

by $0.31

Q3'23

Missed

by $0.16

The last earnings report on August 14 showed earnings per share of -40 cents, meeting the estimate of -40 cents. With 110.07K shares outstanding, the current market capitalization sits at 43.34M.

View a ticker or compare two or three

Compare

ACHL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ACHL
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

245 Hammersmith Road

Phone

+44 2081544600

Employees

242

Web

https://www.achillestx.com